| David Mark Perim, MD | |
|
1400 Forest Glen Rd, Suite 400, Silver Spring, MD 20910-1459 | |
| (301) 589-3324 | |
| (301) 681-7575 |
| Full Name | David Mark Perim |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 39 Years |
| Location | 1400 Forest Glen Rd, Silver Spring, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689666190 | NPI | - | NPPES |
| 521304947 | Other | MD | TAX ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | A43617 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Healthcare Shady Grove Medical Center | Rockville, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Elliot R Goldstein Md And Joel R Schulman Md Pa | 9335120278 | 44 |
News Archive
Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs by the Food and Drug Administration (FDA), according to a study in the January 22/29 issue of JAMA.
It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent of patients with non-small-cell lung cancer (NSCLC) developing bone loss.
Alitair Pharmaceuticals, Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its ion exchange resin formulation of benzonatate.
A team from the University of Illinois at Urbana-Champaign and Northwestern University has devised a novel nuclear magnetic resonance imaging technique that delivers a roughly 10-nanometer spatial resolution.
› Verified 4 days ago
| Entity Name | Elliot R Goldstein Md & Joel R Schulman Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164488300 PECOS PAC ID: 9335120278 Enrollment ID: O20040526001643 |
News Archive
Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs by the Food and Drug Administration (FDA), according to a study in the January 22/29 issue of JAMA.
It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent of patients with non-small-cell lung cancer (NSCLC) developing bone loss.
Alitair Pharmaceuticals, Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its ion exchange resin formulation of benzonatate.
A team from the University of Illinois at Urbana-Champaign and Northwestern University has devised a novel nuclear magnetic resonance imaging technique that delivers a roughly 10-nanometer spatial resolution.
› Verified 4 days ago
| Entity Name | Greater Washington Orthopaedic Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386611614 PECOS PAC ID: 9234118308 Enrollment ID: O20040714000660 |
News Archive
Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs by the Food and Drug Administration (FDA), according to a study in the January 22/29 issue of JAMA.
It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent of patients with non-small-cell lung cancer (NSCLC) developing bone loss.
Alitair Pharmaceuticals, Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its ion exchange resin formulation of benzonatate.
A team from the University of Illinois at Urbana-Champaign and Northwestern University has devised a novel nuclear magnetic resonance imaging technique that delivers a roughly 10-nanometer spatial resolution.
› Verified 4 days ago
| Entity Name | Centers For Advanced Orthopaedics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487093167 PECOS PAC ID: 8123260981 Enrollment ID: O20131024001780 |
News Archive
Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs by the Food and Drug Administration (FDA), according to a study in the January 22/29 issue of JAMA.
It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent of patients with non-small-cell lung cancer (NSCLC) developing bone loss.
Alitair Pharmaceuticals, Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its ion exchange resin formulation of benzonatate.
A team from the University of Illinois at Urbana-Champaign and Northwestern University has devised a novel nuclear magnetic resonance imaging technique that delivers a roughly 10-nanometer spatial resolution.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Mark Perim, MD 1400 Forest Glen Rd, Suite 400, Silver Spring, MD 20910-1459 Ph: (301) 589-3324 | David Mark Perim, MD 1400 Forest Glen Rd, Suite 400, Silver Spring, MD 20910-1459 Ph: (301) 589-3324 |
News Archive
Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs by the Food and Drug Administration (FDA), according to a study in the January 22/29 issue of JAMA.
It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent of patients with non-small-cell lung cancer (NSCLC) developing bone loss.
Alitair Pharmaceuticals, Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its ion exchange resin formulation of benzonatate.
A team from the University of Illinois at Urbana-Champaign and Northwestern University has devised a novel nuclear magnetic resonance imaging technique that delivers a roughly 10-nanometer spatial resolution.
› Verified 4 days ago
Dr. Lawrence Alan Manning, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 8121 Georgia Ave, 701-a, Silver Spring, MD 20910 Phone: 301-587-4180 Fax: 301-587-9141 | |
Dr. Leon J Nesti, MD, PHD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10203 Menlo Ave, Silver Spring, MD 20910 Phone: 301-587-5996 | |
Dr. Leonard F Tassy, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 12201 Plum Orchard Dr, Silver Spring, MD 20904 Phone: 301-572-1000 Fax: 301-572-3398 | |
Dr. Korboi N Evans, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Forest Glen Rd Ste 400, Silver Spring, MD 20910 Phone: 301-251-0509 | |
Jeffrey A Abend, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2101 Medical Park Dr, Suite 110, Silver Spring, MD 20902 Phone: 301-681-5400 Fax: 301-681-5806 | |
Dr. Derek A Kram, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Forest Glen Rd, Suite 400, Silver Spring, MD 20910 Phone: 301-589-3324 Fax: 301-681-7575 | |
Dr. Gabriel L Petruccelli, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 Forest Glen Road, Suite 400, Silver Spring, MD 20910 Phone: 301-589-3324 Fax: 301-681-7575 |